Edition:
United States

EyeGate Pharmaceuticals Inc (EYEG.OQ)

EYEG.OQ on NASDAQ Stock Exchange Capital Market

0.63USD
4:00pm EDT
Change (% chg)

$-0.01 (-1.85%)
Prev Close
$0.64
Open
$0.64
Day's High
$0.64
Day's Low
$0.61
Volume
44,007
Avg. Vol
199,991
52-wk High
$2.00
52-wk Low
$0.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.10 -0.138
FY 2017 Dec '17 0.00 -0.164
Sep '17 0.07 -0.241
Jun '17 0.15 -0.276
Mar '17 0.18 -0.279
FY 2016 Dec '16 0.16 -0.376
Sep '16 0.27 -0.364
Jun '16 0.23 -0.457
Mar '16 0.00 -0.311
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 1.10 1.10 1.10 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.14 -0.14 -0.14 -0.24
Quarter Ending Sep-18 1 -0.08 -0.08 -0.08 -0.23
Year Ending Dec-18 1 -0.36 -0.36 -0.36 0.95
Year Ending Dec-19 1 -0.25 -0.25 -0.25 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.66 32.90
P/E High - Last 5 Yrs. -- 41.40 47.21
P/E Low - Last 5 Yrs. -- 23.48 24.78
Beta -- 0.80 0.79
Price to Sales (TTM) 19.68 3.42 8.29
Price to Book (MRQ) 2.04 3.60 4.33
Price to Tangible Book (MRQ) -- 4.46 5.85
Price to Cash Flow (TTM) -- 19.59 21.98
% Owned Institutions 12.87 1.27 2.41

Dividends

  Company industry sector
Dividend Yield -- 1.78 1.65
Dividend Yield - 5 Year Avg -- 0.78 0.80
Dividend 5 Year Growth Rate -- 2.67 4.07
Payout Ratio(TTM) -- 16.62 17.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 493.95 3.79 4.91
Sales (TTM) vs TTM 1 Yr. Ago 54.49 10.43 12.76
Sales - 5 Yr. Growth Rate -- 7.39 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 50.62 39.00 35.43
EPS (TTM) vs TTM 1 Yr. Ago 44.56 -- --
EPS - 5 Yr. Growth Rate -- 7.03 8.55
Capital Spending - 5 Yr. Growth Rate -- 8.06 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.55 2.53
Current Ratio (MRQ) 1.19 3.62 3.60
LT Debt to Equity (MRQ) 0.06 10.57 12.91
Total Debt to Equity (MRQ) 0.24 13.08 15.97
Interest Coverage (TTM) -- 39.94 34.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.35 54.97
Gross Margin - 5 Yr. Avg. -- 52.67 52.78
EBITD Margin (TTM) -1,061.10 -- --
EBITD - 5 Yr. Avg -3,725.07 18.49 15.93
Operating Margin (TTM) -1,062.83 14.61 0.12
Operating Margin - 5 Yr. Avg. -3,705.83 14.23 11.20
Pre-Tax Margin (TTM) -1,062.89 14.89 2.20
Pre-Tax Margin - 5 Yr. Avg. -3,856.44 14.51 11.41
Net Profit Margin (TTM) -961.15 11.29 -1.22
Net Profit Margin - 5 Yr. Avg. -3,731.81 10.80 7.70
Effective Tax Rate (TTM) -- 22.50 31.30
Effective Tax Rate - 5 Yr. Avg. -- 23.91 24.62

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 841,727,147 731,572,994
Net Income/Employee (TTM) -- 97,990,015 85,104,893
Receivable Turnover (TTM) 2.45 5.60 5.75
Inventory Turnover (TTM) -- 2.52 3.58
Asset Turnover (TTM) 0.11 0.88 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -109.44 10.56 10.07
Return on Assets - 5 Yr. Avg. -135.48 11.70 11.12
Return on Investment (TTM) -306.31 13.20 12.74
Return on Investment - 5 Yr. Avg. -- 15.12 14.40
Return on Equity (TTM) -613.68 14.95 14.64
Return on Equity - 5 Yr. Avg. -- 16.37 15.76
  1 Year 3 Year 5 Year
Sales % -39.11 -- --
EPS (TTM) % 38.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for EyeGate Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.22%
# of Holders: 26
Total Shares Held: 20,907,747
3 Mo. Net Change: 15,132,970
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 11
# Reduced Positions: 8
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.